Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 May;34(5):e70113.
doi: 10.1111/exd.70113.

Blocking of IL-4/IL-13 Signalling With Dupilumab Results in Restoration of Serum and Cutaneous Abnormalities in Netherton Syndrome

Stefan Blunder  1 , Natascha Hermann-Kleiter  2 , Rita Mahmuti  1 , Martin Hermann  3 , Daniela Ortner  1 , Daniela Reider  1 , Verena Moosbrugger-Martinz  1 , Barbara Del Frari  4 , Patrizia Stoitzner  1 , Sandrine Dubrac  1 , Matthias Schmuth  1 , Robert Gruber  1
Affiliations

Blocking of IL-4/IL-13 Signalling With Dupilumab Results in Restoration of Serum and Cutaneous Abnormalities in Netherton Syndrome

Stefan Blunder et al. Exp Dermatol. 2025 May.

Abstract

Netherton syndrome (NS) is a rare ichthyosis caused by SPINK5-null mutations, resulting in erythroderma, ichthyosis linearis circumflexa, and atopic diathesis. Elevated serum IgE levels and activation of the KLK5-PAR2-TSLP axis suggest involvement of Th2-skewed immunity in NS. In this pilot study, we investigated the effects of IL-4/IL-13 blocking with dupilumab on NS features. At baseline, Th2-chemokines CCL11, CCL17, CCL18, CCL26, and serum IgE were more elevated in atopic dermatitis (AD) than in NS vs. controls (ctrls). AD exhibited elevated serum levels of CCL27, LDH, and eosinophils, while NS showed higher levels of IL-9 and IL-18. Epidermal aberrations, including acanthosis and SC-detachment, were present in NS versus ctrls. The number of CD3+ T cells increased, while CD1a + Langerhans cell numbers decreased in NS skin. Amounts of KLK5 were reduced, and the distribution of KLK7 was abnormal in NS epidermis as compared to ctrls. Reduced amounts of FLG, CDSN, and DSG1 highlight impaired keratinocyte late differentiation in NS. Amounts of epidermal TSLP were diminished. Upon dupilumab treatment, clinical improvement in NS began as early as week 8 and continued up to 30 months, with no serious side effects reported. Serum levels of IgE, CCL17, CCL26, IFN-γ and IL-18 decreased upon IL-4/IL-13 blockade, and alterations of cutaneous immune cells improved in NS. Furthermore, the epidermal protease inhibitor WFDC12 expression increased after dupilumab treatment, concurring with improved and partially normalised epidermal structure, including increased FLG, CDSN, and DSG1. These data highlight Th2-skewed immunity in NS and emphasise the amelioration of NS features through dupilumab treatment.

Keywords: IL‐4/IL‐13 blockade; Netherton syndrome; dupilumab; epidermal differentiation; ichthyosis.

PubMed Disclaimer

References

    1. E. Chiticariu and D. Hohl, “Netherton Syndrome: Insights Into Pathogenesis and Clinical Implications,” Journal of Investigative Dermatology 140, no. 6 (2020): 1129–1130.
    1. A. Hovnanian, “Netherton Syndrome: Skin Inflammation and Allergy by Loss of Protease Inhibition,” Cell and Tissue Research 351, no. 2 (2013): 289–300.
    1. E. Petrova and A. Hovnanian, “Advances in Understanding of Netherton Syndrome and Therapeutic Implications,” Expert Opinion on Orphan Drugs 8, no. 11 (2020): 455–487.
    1. L. Samuelov and E. Sprecher, “Peeling Off the Genetics of Atopic Dermatitis‐Like Congenital Disorders,” Journal of Allergy and Clinical Immunology 134, no. 4 (2014): 808–815.
    1. M. Schmuth, V. Martinz, A. R. Janecke, et al., “Inherited Ichthyoses/Generalized Mendelian Disorders of Cornification,” European Journal of Human Genetics 21, no. 2 (2013): 123–133.

MeSH terms

LinkOut - more resources